Skip to main content
. 2017 Jul 1;24(7):677–686. doi: 10.5551/jat.37895

Table 1. Baseline characteristics of the study subjects.

Continuous variables Males (n = 635) Females (n = 944) p-value
Mean SD Mean SD
    Age at enrollment (years) 53.5 9.5 52.6 8.6 0.065
    Body height (cm) 166.9 6.4 156.3 5.5 < 0.0001
    Body weight (kg) 70.2 10.2 59.0 9.8 < 0.0001
    BMI (kg/m2) 25.2 3.2 24.2 3.7 < 0.0001
    Hip circumference (cm) 95.5 6.0 94.6 8.4 0.017
    Waist circumference (cm) 85.7 8.0 77.7 9.2 < 0.0001
    Waist-to-hip ratio (%) 89.6 5.2 82.0 6.4 < 0.0001
    Body shape index (m11/6 × kg−2/3) 0.077 0.004 0.075 0.005 < 0.0001
    SBP (mm Hg) 130.3 18.5 125.7 19.9 < 0.0001
    DBP (mm Hg) 81.4 13.5 77.4 13.3 < 0.0001
    Total cholesterol (mg/dL) 204.4 38.0 209.9 36.7 0.0053
    HDL-C (mg/dL) 50.0 13.1 60.7 15.3 < 0.0001
    LDL-C (mg/dL) 124.9 33.8 123.1 32.7 0.27
    LDL-/HDL-C ratio 2.66 0.96 2.17 0.81 < 0.0001
    Total-/HDL-C ratio 4.32 1.21 3.64 0.99 < 0.0001
    FTG (mg/dL) 135.2 111.9 101.9 66.9 < 0.0001
    FPG (mg/dL) 101.2 28.2 97.7 24.9 0.010
    HbA1c (%) 5.38 0.99 5.77 0.74 0.14
    Insulin (mIU/L) 6.98 5.10 7.60 6.88 0.065
    HOMA index 1.79 1.72 1.89 2.09 0.37
    Log (FTG/LDL-C) 0.36 0.32 0.17 0.31 < 0.0001
    Uric acid (mg/dL) 6.28 1.33 4.82 1.12 < 0.0001
    Number of metabolic components 1.74 1.31 1.52 1.33 0.0014
    10-years CVD risk (%) 17.7 13.9 7.1 6.5 < 0.0001
    Far-wall CCA IMT (mm)
        Right 0.658 0.124 0.626 0.116 < 0.0001
        Left 0.677 0.130 0.637 0.110 < 0.0001
        Mean 0.668 0.113 0.632 0.100 < 0.0001
Dichotomous variables n % n %

    CCA plaque 78 12.3 40 4.2 < 0.0001
    Metabolic syndrome 178 28.0 225 23.8 0.061
    Diabetes mellitus 69 10.9 72 7.6 0.028
    Hypertension 285 44.9 316 33.5 < 0.0001
    History of CVD 25 3.9 15 1.6 0.0036
    Cigarette smoking 303 48.0 72 7.6 < 0.0001
    Alcohol drinking 170 26.8 61 6.5 < 0.0001

Note: BMI, body mass index; CCA, common carotid artery; DBP, diastolic blood pressure; FPG, fasting plasma glucose; FTG, fasting triglycerides; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HOMA, homeostasis model assessment; IMT, intima-media thickness; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure.